METHYLPREDNISOLONE ACETATE Drug Patent Profile
✉ Email this page to a colleague
When do Methylprednisolone Acetate patents expire, and what generic alternatives are available?
Methylprednisolone Acetate is a drug marketed by Amneal, Epic Pharma Llc, Eugia Pharma, Hong Kong, Par Sterile Products, Sagent Pharms Inc, Sandoz, Slayback Pharma Llc, Teva Pharms Usa, and Watson Labs. and is included in seventeen NDAs.
The generic ingredient in METHYLPREDNISOLONE ACETATE is methylprednisolone acetate. There are forty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methylprednisolone Acetate
A generic version of METHYLPREDNISOLONE ACETATE was approved as methylprednisolone acetate by HONG KONG on February 23rd, 2005.
Summary for METHYLPREDNISOLONE ACETATE
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 17 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Clinical Trials: | 38 |
Patent Applications: | 4,391 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for METHYLPREDNISOLONE ACETATE |
DailyMed Link: | METHYLPREDNISOLONE ACETATE at DailyMed |
Recent Clinical Trials for METHYLPREDNISOLONE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Menoufia University | N/A |
Centre hospitalier de l'Université de Montréal (CHUM) | Phase 4 |
Yale University | Phase 2 |
Pharmacology for METHYLPREDNISOLONE ACETATE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for METHYLPREDNISOLONE ACETATE
US Patents and Regulatory Information for METHYLPREDNISOLONE ACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 085595-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 086507-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Amneal | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 210043-001 | May 20, 2019 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sandoz | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 040719-002 | Jan 29, 2009 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Watson Labs | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 085597-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |